ask="6.98"
ask_size="500"
average_daily_volume="1333820"
bid="6.46"
bid_size="100"
book_value="0.05"
change="+0.62"
change_from_200_day_moving_average="1.59"
change_from_50_day_moving_average="0.84"
change_from_52_week_high="-0.70"
change_From_52_week_low="4.77"
change_in_percent="+9.94%"
close="6.86"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.94"
ebitda="-48.19M"
eps_estimate_current_year="-0.87"
eps_estimate_next_quarter="-0.17"
eps_estimate_next_year="-0.88"
ex_dividend_date="N/A"
float_shares="46578000"
high="7.08"
high_52_weeks="7.56"
last_trade_date="3/1/2017"
last_trade_price="6.86"
last_trade_size="92105"
last_trade_time="4:00pm"
low="6.27"
low_52_weeks="2.09"
market_capitalization="505.98M"
moving_average_200_day="5.27"
moving_average_50_day="6.02"
name="BioCryst Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="7.25"
open="6.30"
pe_ratio="N/A"
peg_ratio="-0.32"
percent_change_from_200_day_moving_average="+30.17%"
percent_change_from_50_day_moving_average="+13.91%"
percent_change_from_52_week_high="-9.26%"
percent_change_from_52_week_low="+228.23%"
previous_close="6.24"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="115.56"
price_per_sales="17.46"
revenue="26.35M"
shares_outstanding="73758000"
short_ratio="8.88"
stock_exchange="NMS"
symbol="BCRX"
volume="5065694"
weeks_range_52="2.09 - 7.56"
